Used as a key chiral intermediate in the synthesis of urotensin II receptor antagonists, which are investigated for the treatment of cardiovascular diseases such as hypertension and heart failure. Its stereochemistry plays a critical role in enhancing binding affinity and selectivity toward the urotensin receptor. Due to its stable cyclic sulfonamide structure, it also serves as a scaffold in medicinal chemistry for optimizing pharmacokinetic properties in drug candidates targeting central nervous system disorders.